ReviewJournal of the American Heart Association2020
Financial Toxicity in Atherosclerotic Cardiovascular Disease in the United States: Current State and Future Directions.
Review in Journal of the American Heart Association, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 83 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
83 citing papers in PubMed, 2 syntheses or guidelines pooled it, 132 citations in OpenAlex.
- Evaluation of financial toxicity and associated factors in female patients with breast cancer: a systematic review and meta-analysis.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2023Pooled it
- Financial Toxicity and Its Determinants in Cardiovascular Diseases: A Systematic Review and Bayesian Meta-Analysis.Inquiry : a journal of medical care organization, provision and financingPooled it
- Efficacy and Safety of Inclisiran in Patients with Polyvascular Disease: Pooled, Post Hoc Analysis of the ORION-9, ORION-10, and ORION-11 Phase 3 Randomized Controlled Trials.Cardiovascular drugs and therapy · 2024Trial
- Article
- Financial Toxicity Associated with Biological Medicines: A Scoping Review.Clinical pharmacology and therapeutics · 2026Article
- Financial Distress and Its Determinants in Rheumatoid Arthritis.Arthritis care & research · 2026Article
- Financial Burden in Adults With Chronic Illness in Switzerland: A Secondary Analysis of Qualitative Interviews Using Natural Language Processing and Topic Modeling.JMIR formative research · 2026Article
- Financial toxicity and exercise adherence in stroke patients: a parallel mediation model of perceived social support and self-efficacy.Frontiers in public health · 2026Article
- Prevalence of financial toxicity and construction of a risk prediction model for lung cancer patients at 6 months after discharge.Frontiers in medicine · 2026Article
- Development and Validation of a Risk Screening Model for Depressive Symptoms in Older Inpatients: A Cross-Sectional Study.Clinical interventions in aging · 2026Article
- Construction of a home-based social support service content framework for Chinese patients with chronic heart failure based on Maslow's hierarchy of needs.Frontiers in medicine · 2026Article
- Development of a machine learning model for cardiovascular diseases risk prediction in older HIV/AIDS patients in Southern China from an eleven-year cohort study.BMC infectious diseases · 2025Article
- Social Determinants of Health Correlates and Atherosclerotic Cardiovascular Disease Risk Among Adults in Baltimore: The EngAGE With Heart Study.Journal of the American Heart Association · 2025Article
- Perceptions of high-sensitivity C-reactive protein testing (hsCRP) in atherosclerotic cardiovascular disease: a US survey on cardiologists and nephrologists.Future cardiology · 2025Article
- Depressive symptoms and chronic disease trajectories and predictors in middle-aged and older adults in China: An eight-year multi-trajectory analysis.Global health & medicine · 2025Article
- Validation of the Chinese version of the financial toxicity scale in patients with wet age-related macular degeneration.Journal of patient-reported outcomes · 2025Article
- Quality of life and associated factors among people with chronic diseases in Hubei, China: a cross-sectional study.BMC public health · 2025Article
- Vascular clues in joint degeneration: a cross-sectional study on the association between aortic knob width, aortic arch calcification, and the severity of hand and knee osteoarthritis.BMC musculoskeletal disorders · 2025Article
- Delayed or forgone medical care associated with increased resource utilization and health care expenditures among patients with peripheral artery disease in the United States.Journal of vascular surgery · 2025Article
- Disparities in cardiovascular disease outcomes and economic burdens among minorities in southeastern Virginia.BMC cardiovascular disorders · 2025Observational
23 more citing papers are in PubMed but not listed here.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 2 institutions in 1 country.
Funding
Abstract
Atherosclerotic cardiovascular disease (ASCVD) has posed an increasing burden on Americans and the United States healthcare system for decades. In addition, ASCVD has had a substantial economic impact, with national expenditures for ASCVD projected to increase by over 2.5-fold from 2015 to 2035. This rapid increase in costs associated with health care for ASCVD has consequences for payers, healthcare providers, and patients. The issues to patients are particularly relevant in recent years, with a growing trend of shifting costs of treatment expenses to patients in various forms, such as high deductibles, copays, and coinsurance. Therefore, the issue of
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.